These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37767960)

  • 1. Development and validation of cardiovascular risk prediction equations in 76 000 people with known cardiovascular disease.
    Holt A; Batinica B; Liang J; Kerr A; Crengle S; Hudson B; Wells S; Harwood M; Selak V; Mehta S; Grey C; Lamberts M; Jackson R; Poppe KK
    Eur J Prev Cardiol; 2024 Jan; 31(2):218-227. PubMed ID: 37767960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of alternative cardiovascular risk prediction equations for population health planning: a routine health data linkage study of 1.7 million New Zealanders.
    Mehta S; Jackson R; Pylypchuk R; Poppe K; Wells S; Kerr AJ
    Int J Epidemiol; 2018 Oct; 47(5):1571-1584. PubMed ID: 30010781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of the American Heart Association's PREVENT Equations.
    Khan SS; Matsushita K; Sang Y; Ballew SH; Grams ME; Surapaneni A; Blaha MJ; Carson AP; Chang AR; Ciemins E; Go AS; Gutierrez OM; Hwang SJ; Jassal SK; Kovesdy CP; Lloyd-Jones DM; Shlipak MG; Palaniappan LP; Sperling L; Virani SS; Tuttle K; Neeland IJ; Chow SL; Rangaswami J; Pencina MJ; Ndumele CE; Coresh J;
    Circulation; 2024 Feb; 149(6):430-449. PubMed ID: 37947085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of cardiovascular disease risk prediction equations in more than 14 000 survivors of cancer in New Zealand primary care: a validation study.
    Tawfiq E; Selak V; Elwood JM; Pylypchuk R; Tin ST; Harwood M; Grey C; McKeage M; Wells S
    Lancet; 2023 Feb; 401(10374):357-365. PubMed ID: 36702148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of risk prediction equations to estimate future risk of heart failure in patients with diabetes: a prospective cohort study.
    Hippisley-Cox J; Coupland C
    BMJ Open; 2015 Sep; 5(9):e008503. PubMed ID: 26353872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.
    Pylypchuk R; Wells S; Kerr A; Poppe K; Riddell T; Harwood M; Exeter D; Mehta S; Grey C; Wu BP; Metcalf P; Warren J; Harrison J; Marshall R; Jackson R
    Lancet; 2018 May; 391(10133):1897-1907. PubMed ID: 29735391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are competing-risk models superior to standard Cox models for predicting cardiovascular risk in older adults? Analysis of a whole-of-country primary prevention cohort aged ≥65 years.
    Cooper H; Wells S; Mehta S
    Int J Epidemiol; 2022 May; 51(2):604-614. PubMed ID: 34109395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do cardiovascular risk prediction equations developed among 30-74 year olds perform in older age groups? A validation study in 125 000 people aged 75-89 years.
    Mehta S; Jackson R; Poppe K; Kerr AJ; Pylypchuk R; Wells S
    J Epidemiol Community Health; 2020 Jun; 74(6):527-533. PubMed ID: 32144211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study.
    Pylypchuk R; Wells S; Kerr A; Poppe K; Harwood M; Mehta S; Grey C; Wu BP; Selak V; Drury PL; Chan WC; Orr-Walker B; Murphy R; Mann J; Krebs JD; Zhao J; Jackson R
    Lancet; 2021 Jun; 397(10291):2264-2274. PubMed ID: 34089656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study.
    Abdel-Qadir H; Thavendiranathan P; Austin PC; Lee DS; Amir E; Tu JV; Fung K; Anderson GM
    Eur Heart J; 2019 Dec; 40(48):3913-3920. PubMed ID: 31318428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions.
    Hageman SHJ; Kaptoge S; de Vries TI; Lu W; Kist JM; van Os HJA; Numans ME; Läll K; Bobak M; Pikhart H; Kubinova R; Malyutina S; Pająk A; Tamosiunas A; Erbel R; Stang A; Schmidt B; Schramm S; Bolton TR; Spackman S; Bakker SJL; Blaha M; Boer JMA; Bonnefond A; Brenner H; Brunner EJ; Cook NR; Davidson K; Dennison E; Donfrancesco C; Dörr M; Floyd JS; Ford I; Fu M; Gansevoort RT; Giampaoli S; Gillum RF; Gómez-de-la-Cámara A; Håheim LL; Hansson PO; Harms P; Humphries SE; Ikram MK; Jukema JW; Kavousi M; Kiechl S; Kucharska-Newton A; Pablos DL; Matsushita K; Meyer HE; Moons KGM; Mortensen MB; Muilwijk M; Nordestgaard BG; Packard C; Pamieri L; Panagiotakos D; Peters A; Potier L; Providencia R; Psaty BM; Ridker PM; Rodriguez B; Rosengren A; Sattar N; Schöttker B; Schwartz JE; Shea S; Shipley MJ; Sofat R; Thorand B; Verschuren WMM; Völzke H; Wareham NJ; Westbury L; Willeit P; Zhou B; Danesh J; Visseren FLJ; Di Angelantonio E; Pennells L; Dorresteijn JAN
    Eur J Prev Cardiol; 2024 Oct; 31(14):1690-1699. PubMed ID: 38752762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting cardiovascular disease risk across the atherosclerotic disease continuum.
    Poppe KK; Wells S; Jackson R; Doughty RN; Kerr AJ
    Eur J Prev Cardiol; 2022 Feb; 28(18):2010-2017. PubMed ID: 33624049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment drop-in in a contemporary cohort used to derive cardiovascular risk prediction equations.
    Liang J; Jackson RT; Pylypchuk R; Choi Y; Chung C; Crengle S; Gao P; Grey C; Harwood M; Holt A; Kerr A; Mehta S; Wells S; Poppe K
    Heart; 2024 Aug; 110(17):1083-1089. PubMed ID: 38960588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
    Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
    Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing and validating a cardiovascular risk score for patients in the community with prior cardiovascular disease.
    Poppe KK; Doughty RN; Wells S; Gentles D; Hemingway H; Jackson R; Kerr AJ
    Heart; 2017 Jun; 103(12):891-892. PubMed ID: 28232378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2013 May; 346():f2573. PubMed ID: 23641033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of CVD risk equations for older patients assessed in general practice: a cohort study.
    Wells S; Pylypchuk R; Mehta S; Kerr A; Selak V; Poppe K; Grey C; Jackson R
    N Z Med J; 2020 Jun; 133(1517):32-55. PubMed ID: 32595220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular preventive pharmacotherapy stratified by predicted cardiovascular risk: a national data linkage study.
    Mehta S; Zhao J; Poppe K; Kerr AJ; Wells S; Exeter DJ; Selak V; Grey C; Jackson R
    Eur J Prev Cardiol; 2022 Feb; 28(17):1905-1913. PubMed ID: 33580793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cardiovascular risk prediction model for older people: Development and validation in a primary care population.
    van Bussel EF; Richard E; Busschers WB; Steyerberg EW; van Gool WA; Moll van Charante EP; Hoevenaar-Blom MP
    J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1145-1152. PubMed ID: 31294917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.